Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
Authors
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

Contacts

Manley, Maria Isabel
Partner
Boyle, Chris
Partner

Capabilities

Suggested News & Insights

Animal Health, Nutrition & Technology Innovation – Shaping the Future of Animal HealthMonday, March 2, 2026 - Tuesday, March 3, 2026
Speaking Engagements
Veterinary Biologics and Biosimilars: Routes to Approval and Commercialization in the U.S., EU, and UKFebruary 20, 2026
Animal Health Update
Drug Pricing and Medicaid Rebate Reporting: Enforcement Risk RemainsFebruary 17, 2026
Reuters
Sidley Represents Vivo Capital on Its Acquisition of Dutscher GroupFebruary 4, 2026
Announcements
Sidley Represents RoundTable Healthcare Partners in Its Partnership and Investment in ColorescienceFebruary 2, 2026
Announcements
Sidley Represents Simcere in €1 Billion Licensing and Collaboration Agreement With Boehringer IngelheimJanuary 29, 2025
Announcements